Lupin gets USFDA’s tentative approval for Arformoterol Tartrate Inhalation Solution

29 Apr 2020 Evaluate

Lupin has received tentative approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials, from the United States Food and Drug Administration (USFDA) to market a generic version of Brovana Inhalation Solution, 15 mcg/2 mL of Sunovion Pharmaceuticals Inc. (Sunovion).

Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials are indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2128.20 9.95 (0.47%)
19-Dec-2025 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1747.40
Dr. Reddys Lab 1281.30
Cipla 1508.55
Zydus Lifesciences 915.60
Lupin 2128.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×